Search
Loading search results...
Search Results for "CIPO2015: Durable Immune Control of ALL Requires a Multi-Antigen Immune Response"
CIPO2015: Durable Immune Control of ALL Requires a Multi-Antigen Immune Response
CIPO2015: Genetically Engineered Macrophages: Overcoming the Brain Tumor Microenvironment
CIPO2015: Pre-clinical and Clinical Development of CD22-Targeted CAR T Cells
CIPO2015: Enhancing the IQ of CAR T Cells Using the Synthetic Biology Tool Box
CIPO2015: Clues from Graft-Versus-Host Disease to Design Successful Immunotherapy
CIPO2015: CD19 CAR T Cells During Therapy in Relapsed ALL Pediatric and Young Adult Patients
CIPO2015: Anti-GD2 mAb and Next Generation mAb-Based Agents, KIR, Cytokines and Combination Therapy
Immunotherapy priming with neo-antigens
T-Cell Therapies - Catherine Bollard, MD | Pediatric Grand Rounds
CIPO2015: Targeting Chondroitin Sulfate Glycans in Childhood Cancer
The Complexities of the CAR T Cell: Implications for Clinical Trial Designs
Developing Personalized Cancer Neoantigen Vaccines